These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays. Damm DD, Jones DM. Gen Dent; 2013 Aug; 61(5):33-8. PubMed ID: 23928436 [Abstract] [Full Text] [Related]
4. [A case of bisphosphonate-related osteonecrosis of the jaw in a patient who had received intravenous bisphosphonates]. Ishikawa T. Gan To Kagaku Ryoho; 2014 Feb; 41(2):225-7. PubMed ID: 24743202 [Abstract] [Full Text] [Related]
7. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development? Otto S, Tröltzsch M, Jambrovic V, Panya S, Probst F, Ristow O, Ehrenfeld M, Pautke C. J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767 [Abstract] [Full Text] [Related]
14. Osteonecrosis of the jaw onset times are based on the route of bisphosphonate therapy. Fleisher KE, Jolly A, Venkata UD, Norman RG, Saxena D, Glickman RS. J Oral Maxillofac Surg; 2013 Mar; 71(3):513-9. PubMed ID: 22999296 [Abstract] [Full Text] [Related]
17. Dental sinus tracts mimicking scrofuloderma: cutaneous presentation of underlying bisphosphonate-related osteonecrosis of the jaw. Kang HS, Lee JW, Kim JS. Clin Exp Dermatol; 2011 Aug; 36(6):624-7. PubMed ID: 21771007 [Abstract] [Full Text] [Related]
18. Bisphosphonate-associated osteonecrosis of jaw reoccurrence after methotrexate therapy: a case report. Alsalleeh F, Keippel J, Adams L, Bavitz B. J Endod; 2014 Sep; 40(9):1505-7. PubMed ID: 25146044 [Abstract] [Full Text] [Related]
19. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan. Yuh DY, Chang TH, Huang RY, Chien WC, Lin FG, Fu E. J Dent; 2014 Oct; 42(10):1343-52. PubMed ID: 24907558 [Abstract] [Full Text] [Related]